Non-Current Assets

Neurocrine Biosciences·Balance Sheet Statement·18 metrics

Breakdown

Loading...

Metrics

Deferred tax assets

Deferred Tax Assets and Other Non-Current Assets

Available-for-sale securities

Equity securities

Net Investment in Lease

Long-term marketable securities

Deferred tax assets

Operating lease right-of-use assets

Other non-current assets

Operating Lease Income - 2026 (Lessor)

Operating Lease Income - 2027 (Lessor)

Operating Lease Income - 2028 (Lessor)

Operating lease right-of-use assets

Operating Lease Right-of-Use Assets in Other Assets

Other non-current assets

Property and equipment, net

Software and Technology Licenses, Net

Total assets